Literature DB >> 33296069

Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach.

Robério Amorim de Almeida Pondé1,2.   

Abstract

Wild-type HBV infection is followed by the blood expression of its widely known serological markers of infection, and designated as, hepatitis B virus surface antigen (HBsAg) and its antibody (anti-HBs), anti-HBc antibodies (IgM/IgG), and hepatitis B virus 'e' antigen (HBeAg) and its antibody (anti-HBe). These markers are detected as the infection develops and its kinetic behavior serves as a basis for monitoring the disorder and for diagnosing the clinical form or infection phase. Among these, the HBeAg-anti-HBe system markers demonstrate a dynamic profile whose interpretation, both in the acute or chronic HBV infection context, can offer greater difficulty to the health professionals, due to its particularities. This review offers a revisit to the markers dynamics of this system in the acute and chronic HBV infection and to the clinical and laboratory significance of its expression in these two clinical contexts.

Entities:  

Keywords:  Acute HBV infection; Anti-HBe antibodies; Chronic HBV infection; HBe Antigen; Hepatitis B virus

Mesh:

Substances:

Year:  2020        PMID: 33296069     DOI: 10.1007/s11033-020-06056-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  70 in total

1.  Expression of hepatitis B virus genes in early embryonic cells originated from hamster ova and human spermatozoa transfected with the complete viral genome.

Authors:  Bahy Ahmed Ali; Tian-Hua Huang; Halima-Hassan Salem; Qing-Dong Xie
Journal:  Asian J Androl       Date:  2006-05       Impact factor: 3.285

2.  Comparative sensitivity of HBV NATs and HBsAg assays for detection of acute HBV infection.

Authors:  Robin Biswas; Edward Tabor; Chu Chieh Hsia; David J Wright; Megan E Laycock; Eberhard W Fiebig; Lorraine Peddada; Richard Smith; George B Schreiber; Jay S Epstein; George J Nemo; Michael P Busch
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

Review 3.  Nucleic acid amplification technology methods used in blood donor screening.

Authors:  P R Grant; M P Busch
Journal:  Transfus Med       Date:  2002-08       Impact factor: 2.019

Review 4.  Assessing the impact of HBV NAT on window period reduction and residual risk.

Authors:  Steven H Kleinman; Michael P Busch
Journal:  J Clin Virol       Date:  2006-05       Impact factor: 3.168

5.  HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

Authors:  Akira Yoshikawa; Yuhko Gotanda; Masako Itabashi; Kiyoshi Minegishi; Kimihiro Kanemitsu; Kusuya Nishioka
Journal:  Vox Sang       Date:  2005-02       Impact factor: 2.144

6.  High levels of hepatitis B virus DNA in body fluids from chronic carriers.

Authors:  K Kidd-Ljunggren; A Holmberg; J Bläckberg; B Lindqvist
Journal:  J Hosp Infect       Date:  2006-10-12       Impact factor: 3.926

7.  Stress-relaxation of stretched callus strips. Influence of various solvent and solution environment on mechanoelastic properties of cornified epithelium.

Authors:  T Higuchi; W J Tillman
Journal:  Arch Environ Health       Date:  1965-10

Review 8.  Mother-to-infant transmission of hepatitis B virus: challenges and perspectives.

Authors:  Yi-Fen Shih; Chun-Jen Liu
Journal:  Hepatol Int       Date:  2017-10-24       Impact factor: 6.047

9.  The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study.

Authors:  G B Schreiber; M P Busch; S H Kleinman; J J Korelitz
Journal:  N Engl J Med       Date:  1996-06-27       Impact factor: 91.245

Review 10.  Hepatitis B virus infection in children and adolescents.

Authors:  Giuseppe Indolfi; Philippa Easterbrook; Geoffrey Dusheiko; George Siberry; Mei-Hwei Chang; Claire Thorne; Marc Bulterys; Po-Lin Chan; Manal H El-Sayed; Carlo Giaquinto; Maureen M Jonas; Tammy Meyers; Nick Walsh; Stefan Wirth; Martina Penazzato
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-04-11
View more
  2 in total

1.  Application Effect and Accuracy Analysis of Electrochemiluminescence Immunoassay and Enzyme-Linked Immunosorbent Assay in the Serological Test of Hepatitis B Virus.

Authors:  Yifei Lian; Hongran Fu; Xiaoyi Xu; Chuanyu Ju
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-04       Impact factor: 2.650

Review 2.  Novel Biomarkers of Hepatitis B Virus and Their Use in Chronic Hepatitis B Patient Management.

Authors:  Alicia Vachon; Carla Osiowy
Journal:  Viruses       Date:  2021-05-21       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.